Exact Mass: 334.0372

Exact Mass Matches: 334.0372

Found 58 metabolites which its exact mass value is equals to given mass value 334.0372, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-(3,4-Diacetoxybut-1-ynyl)-2,2-bithiophene

(+)-5-(3,4-Diacetoxybut-1-ynyl)-2,2-bithiophene

C16H14O4S2 (334.0333)


   

Lormetazepam

7-Chloro-5-(O-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one

C16H12Cl2N2O2 (334.0276)


Lormetazepam, also known as methyllorazepam or (+-)-lorazepam, is a member of the class of compounds known as 1,4-benzodiazepines. 1,4-benzodiazepines are organic compounds containing a benzene ring fused to a 1,4-azepine. Lormetazepam is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lormetazepam can be found in potato, which makes lormetazepam a potential biomarker for the consumption of this food product. Lormetazepam is a non-carcinogenic (not listed by IARC) potentially toxic compound. Lormetazepam is a drug which is used for the treatment of short-term insomnia [l927. The Dutch, British, and French system called the System of Objectified Judgement Analysis for assessing whether drugs should be included in drug formularies based on clinical efficacy, adverse effects, pharmacokinetic properties, toxicity, and drug interactions was used to assess lormetazepam. A Dutch analysis using the system found that lormetazepam could be suitable to be included in drug prescribing formularies, although zolpidem, zopiclone, and temazepam had higher scores and thus can be seen as relatively favorable . The primary manifestation of overdosage ranges from drowsiness to coma and symptoms may include ataxia, hypotension, hypotonia, respiratory depression which may lead to death [L927]. Lormetazepam (INN, or methyl-lorazepam, is a drug which is a short to intermediate acting 3-hydroxy benzodiazepine derivative. It possesses hypnotic, anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Lormetazepam is considered a hypnotic benzodiazepine and is officially indicated for moderate to severe insomnia. Lormetazepam is a short-acting benzodiazepine and is sometimes used in patients who have difficulty in maintaining sleep or falling asleep. Hypnotics should only be used on a short-term basis or, in those with chronic insomnia, on an occasional basis. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

3,3',4',5,6,7,8-Heptahydroxyflavone

2-(3,4-Dihydroxyphenyl)-3,5,6,7,8-pentahydroxy-4H-1-benzopyran-4-one, 9ci

C15H10O9 (334.0325)


3,3,4,5,6,7,8-Heptahydroxyflavone is isolated from petals of African marigold (Tagetes erecta

   

5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate

({2,3-dihydroxy-5-[(5-oxooxolan-2-yl)methyl]phenoxy}methoxy)sulphonic acid

C12H14O9S (334.0359)


5-(3,4,5-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate belongs to the family of Methoxyphenols and Derivatives. These are compounds containing a methoxy group attached to the benzene ring of a phenol moiety.

   

(5R,6S)-3-(2-Carbamoyloxyethylsulfanyl)-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

3-{[2-(C-hydroxycarbonimidoyloxy)ethyl]sulphanyl}-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C11H14N2O6S2 (334.0293)


   

1-(2,4-Dichlorobenzyl)-1H-indazole-3-carbohydrazide

1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carbohydrazide

C15H12Cl2N4O (334.0388)


Adjudin is an extensively studied male contraceptive with a superior mitochondria-inhibitory effect. Adjudin is also a potent Cl- channel blocker.

   

Chlorsulfaquinoxaline

4-amino-N-(5-chloroquinoxalin-2-yl)benzene-1-sulfonamide

C14H11ClN4O2S (334.0291)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

Salacinol

(2S,3S)-4-((1S,2R,3S,4S)-3,4-DIHYDROXY-2-(hydroxymethyl)tetrahydro-1H-thiophen-1-ium-1-yl)-1,3-dihydroxybutan-2-yl sulphuric acid

C9H18O9S2 (334.0392)


   

6-Bromo-1,8-dihydroaplysinopsin

6-Bromo-1,8-dihydroaplysinopsin

C14H15BrN4O (334.0429)


   
   

3,5,6,7,2,3,4-Heptahydroxyflavone

3,5,6,7,2,3,4-Heptahydroxyflavone

C15H10O9 (334.0325)


   
   

8-Hydroxyquercetagetin

3,5,6,7,8,3,4-Heptahydroxyflavone

C15H10O9 (334.0325)


   
   
   
   
   
   

Lormetazepam

Lormetazepam

C16H12Cl2N2O2 (334.0276)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Chiodectonic acid

Chiodectonic acid

C15H10O9 (334.0325)


   

Loramet

7-Chloro-5-(O-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one

C16H12Cl2N2O2 (334.0276)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

4-([2,2-bithiophen]-5-yl)but-3-yne-1,2-diyl diacetate

4-([2,2-bithiophen]-5-yl)but-3-yne-1,2-diyl diacetate

C16H14O4S2 (334.0333)


   

1-(2-BROMOBENZYL)-1-METHOXY-3-PHENYLUREA

1-(2-BROMOBENZYL)-1-METHOXY-3-PHENYLUREA

C15H15BrN2O2 (334.0317)


   

3-[4-[(4-CHLOROBENZYL)OXY]PHENYL]-5-(CHLOROMETHYL)-1,2,4-OXADIAZOLE

3-[4-[(4-CHLOROBENZYL)OXY]PHENYL]-5-(CHLOROMETHYL)-1,2,4-OXADIAZOLE

C16H12Cl2N2O2 (334.0276)


   

5-bromo-1-(2-oxo-2-pyrrolidin-1-ylethyl)indole-3-carbaldehyde

5-bromo-1-(2-oxo-2-pyrrolidin-1-ylethyl)indole-3-carbaldehyde

C15H15BrN2O2 (334.0317)


   

N-(4-chlorophenyl)-1-(pyrimidin-2-yl)-1H-pyrrole-2-sulfonamide

N-(4-chlorophenyl)-1-(pyrimidin-2-yl)-1H-pyrrole-2-sulfonamide

C14H11ClN4O2S (334.0291)


   

2-(4-BROMOPHENYL)-1,1-DIPHENYLETHYLENE

2-(4-BROMOPHENYL)-1,1-DIPHENYLETHYLENE

C20H15Br (334.0357)


   

2,2-Dithiobis(3-methylbenzoic acid)

2,2-Dithiobis(3-methylbenzoic acid)

C16H14O4S2 (334.0333)


   

3,5-BIS(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

3,5-BIS(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

C15H8F6O2 (334.0428)


   

(4-TERT-BUTYLPHENYL)DIPHENYLSULFONIUMTRIFLATE

(4-TERT-BUTYLPHENYL)DIPHENYLSULFONIUMTRIFLATE

C15H8F6O2 (334.0428)


   

Bromotriphenylethene

Bromotriphenylethene

C20H15Br (334.0357)


   

triphenylphosphine hydrochloride

triphenylphosphine hydrochloride

C18H17Cl2P (334.0445)


   

12-Bromomethyl-7-methylbenz[a]anthracene

12-Bromomethyl-7-methylbenz[a]anthracene

C20H15Br (334.0357)


   

3,5-BIS(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

3,5-BIS(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

C15H8F6O2 (334.0428)


   

4-bromo-9-methyl-9-phenyl-9H-fluorene

4-bromo-9-methyl-9-phenyl-9H-fluorene

C20H15Br (334.0357)


   

2-bromo-9-methyl-9-phenyl-9H-fluorene

2-bromo-9-methyl-9-phenyl-9H-fluorene

C20H15Br (334.0357)


   

7-(benzyloxy)-2,4-dichloro-6-methoxyquinazoline

7-(benzyloxy)-2,4-dichloro-6-methoxyquinazoline

C16H12Cl2N2O2 (334.0276)


   

1-(4-BROMOBENZYL)-1-METHOXY-3-PHENYLUREA

1-(4-BROMOBENZYL)-1-METHOXY-3-PHENYLUREA

C15H15BrN2O2 (334.0317)


   

Dimethyl 2,2-dithiobisbenzoate

Dimethyl 2,2-dithiobisbenzoate

C16H14O4S2 (334.0333)


   

7-Bromomethyl-12-methylbenz(A)anthracene

7-Bromomethyl-12-methylbenz(A)anthracene

C20H15Br (334.0357)


   

N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide

N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide

C15H14N2O3S2 (334.0446)


   

3-(1-hydroxy-1H-1,2,3-benzotriazole-6-sulfonamido)benzoic acid

3-(1-hydroxy-1H-1,2,3-benzotriazole-6-sulfonamido)benzoic acid

C13H10N4O5S (334.0372)


   

5-[[(5,6-Dimethyl-4-thieno[2,3-d]pyrimidinyl)thio]methyl]-2-furancarboxylic acid methyl ester

5-[[(5,6-Dimethyl-4-thieno[2,3-d]pyrimidinyl)thio]methyl]-2-furancarboxylic acid methyl ester

C15H14N2O3S2 (334.0446)


   

1-Bromo-3-(2,2-diphenylethenyl)benzene

1-Bromo-3-(2,2-diphenylethenyl)benzene

C20H15Br (334.0357)


   

5-(4-chloro-2-hydroxy-phenoxy)-N-(5-methylisoxazol-3-yl)furan-2-carboxamide

5-(4-chloro-2-hydroxy-phenoxy)-N-(5-methylisoxazol-3-yl)furan-2-carboxamide

C15H11ClN2O5 (334.0356)


   

(2R,3R,4S,5R,6S)-2,3,4,5,6-pentahydroxy-7-oxo-8-phosphonooxyoctanoic acid

(2R,3R,4S,5R,6S)-2,3,4,5,6-pentahydroxy-7-oxo-8-phosphonooxyoctanoic acid

C8H15O12P (334.0301)


   

2-hydroxy-2-[(2R,3S,4R,5S,6R)-3,4,5,6-tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl]acetic acid

2-hydroxy-2-[(2R,3S,4R,5S,6R)-3,4,5,6-tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl]acetic acid

C8H15O12P (334.0301)


   

2-(2-bromo-4-methylphenoxy)-N-(pyridin-2-ylmethyl)acetamide

2-(2-bromo-4-methylphenoxy)-N-(pyridin-2-ylmethyl)acetamide

C15H15BrN2O2 (334.0317)


   

4-Methyl-5-thieno[3,2-b]pyrrolecarboxylic acid [2-oxo-2-(thiophen-2-ylmethylamino)ethyl] ester

4-Methyl-5-thieno[3,2-b]pyrrolecarboxylic acid [2-oxo-2-(thiophen-2-ylmethylamino)ethyl] ester

C15H14N2O3S2 (334.0446)


   

[1-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-3-oxopropyl] hydrogen sulate

[1-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-3-oxopropyl] hydrogen sulate

C12H14O9S (334.0359)


   

5-(3,4,5-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate

5-(3,4,5-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate

C12H14O9S (334.0359)


   

H4R antagonist 1

H4R antagonist 1

C11H11BrN8 (334.029)


H4R antagonist 1 is a potent and highly selective histamine H4 receptor (H4R) antagonist with an IC50 of 27 nM. H4R antagonist 1 does not show any noticeable binding affinity to other subtypes of histamine receptors, H1R, H2R, and H3R[1].

   

n-[(4s)-4-(5-bromo-1h-indol-3-yl)-3,4,5,6-tetrahydropyrimidin-2-yl]ethanimidic acid

n-[(4s)-4-(5-bromo-1h-indol-3-yl)-3,4,5,6-tetrahydropyrimidin-2-yl]ethanimidic acid

C14H15BrN4O (334.0429)


   

(2r)-1-(acetyloxy)-4-{[2,2'-bithiophen]-5-yl}but-3-yn-2-yl acetate

(2r)-1-(acetyloxy)-4-{[2,2'-bithiophen]-5-yl}but-3-yn-2-yl acetate

C16H14O4S2 (334.0333)


   

(5s)-5-[(6-bromo-1h-indol-3-yl)methyl]-2-imino-1,3-dimethylimidazolidin-4-one

(5s)-5-[(6-bromo-1h-indol-3-yl)methyl]-2-imino-1,3-dimethylimidazolidin-4-one

C14H15BrN4O (334.0429)


   

3,5,6,7-tetrahydroxy-2-(2,3,4-trihydroxyphenyl)chromen-4-one

3,5,6,7-tetrahydroxy-2-(2,3,4-trihydroxyphenyl)chromen-4-one

C15H10O9 (334.0325)


   

n-[4-(5-bromo-1h-indol-3-yl)-3,4,5,6-tetrahydropyrimidin-2-yl]ethanimidic acid

n-[4-(5-bromo-1h-indol-3-yl)-3,4,5,6-tetrahydropyrimidin-2-yl]ethanimidic acid

C14H15BrN4O (334.0429)


   

1-(acetyloxy)-4-{[2,2'-bithiophen]-5-yl}but-3-yn-2-yl acetate

1-(acetyloxy)-4-{[2,2'-bithiophen]-5-yl}but-3-yn-2-yl acetate

C16H14O4S2 (334.0333)